tiprankstipranks
MicroPort CardioFlow Medtech Corp. (HK:2160)
:2160
Hong Kong Market
2160
MicroPort CardioFlow Medtech Corp.
RESEARCH TOOLSreports
Want to see HK:2160 full AI Analyst Report?

MicroPort CardioFlow Medtech Corp. (2160) Ratios

1 Followers

MicroPort CardioFlow Medtech Corp. Ratios

HK:2160's free cash flow for Q4 2025 was ¥0.34. For the 2025 fiscal year, HK:2160's free cash flow was decreased by ¥ and operating cash flow was ¥-0.48. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.53 2.53 3.86 10.55 12.82
Quick Ratio
 1.94 1.94 3.55 9.91 12.17
Cash Ratio
 0.47 0.47 0.25 5.50 10.53
Solvency Ratio
 -0.01 -0.01 -0.05 -1.64 -1.76
Operating Cash Flow Ratio
 >-0.01 >-0.01 -0.26 -1.07 -1.03
Short-Term Operating Cash Flow Coverage
 -0.02 -0.02 -2.98 0.00 0.00
Net Current Asset Value
¥ -20.53M¥ -20.53M¥ 1.22B¥ 1.80B¥ 2.02B
Leverage Ratios
Debt-to-Assets Ratio
 0.35 0.35 0.03 0.03 0.03
Debt-to-Equity Ratio
 0.91 6.34 0.04 0.03 0.03
Debt-to-Capital Ratio
 0.48 0.86 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
 0.42 0.84 <0.01 0.00 0.00
Financial Leverage Ratio
 2.61 18.27 1.22 1.10 1.09
Debt Service Coverage Ratio
 -0.07 -0.07 -2.92 -100.64 -67.66
Interest Coverage Ratio
 -9.59 -9.59 -16.59 -80.12 -72.59
Debt to Market Cap
 1.46 2.76 0.03 0.00 0.00
Interest Debt Per Share
 16.61 16.61 0.17 0.03 0.04
Net Debt to EBITDA
 -151.16 -151.16 0.28 2.58 5.09
Profitability Margins
Gross Profit Margin
54.80%54.80%69.48%68.39%64.59%
EBIT Margin
-26.93%-26.93%-38.13%-136.72%-145.74%
EBITDA Margin
-1.88%-1.88%-31.34%-114.82%-138.60%
Operating Profit Margin
-26.93%-26.93%-17.32%-93.29%-150.02%
Pretax Profit Margin
-31.62%-31.62%-12.79%-137.88%-179.78%
Net Profit Margin
-32.99%-32.99%-13.68%-140.25%-181.02%
Continuous Operations Profit Margin
-33.00%-33.00%-14.73%-140.25%-181.02%
Net Income Per EBT
104.35%104.35%106.88%101.72%100.69%
EBT Per EBIT
117.42%117.42%73.88%147.80%119.84%
Return on Assets (ROA)
-2.81%-2.81%-1.85%-18.30%-15.14%
Return on Equity (ROE)
-6.63%-51.43%-2.26%-20.20%-16.50%
Return on Capital Employed (ROCE)
-2.95%-2.95%-2.79%-13.16%-13.33%
Return on Invested Capital (ROIC)
-2.82%-2.82%-2.72%-13.00%-13.19%
Return on Tangible Assets
-3.57%-3.57%-1.99%-18.32%-16.01%
Earnings Yield
-65.08%-24.64%-3.31%-13.59%-8.33%
Efficiency Ratios
Receivables Turnover
 0.63 0.63 2.11 3.33 4.54
Payables Turnover
 0.69 0.69 2.77 2.00 1.86
Inventory Turnover
 0.30 0.30 0.82 0.87 0.78
Fixed Asset Turnover
 0.56 0.56 0.71 1.71 1.04
Asset Turnover
 0.09 0.09 0.14 0.13 0.08
Working Capital Turnover Ratio
 0.26 0.28 0.23 0.17 0.11
Cash Conversion Cycle
 1.28K 1.28K 489.36 348.74 353.09
Days of Sales Outstanding
 578.91 578.91 173.20 109.64 80.36
Days of Inventory Outstanding
 1.23K 1.23K 447.77 421.96 468.55
Days of Payables Outstanding
 528.22 528.22 131.62 182.87 195.81
Operating Cycle
 1.81K 1.81K 620.97 531.61 548.91
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.03 -0.03 -0.24 -0.09 -0.08
Free Cash Flow Per Share
 -0.39 -0.39 -0.58 -0.10 -0.10
CapEx Per Share
 0.35 0.35 0.34 0.01 0.02
Free Cash Flow to Operating Cash Flow
 11.53 11.53 2.42 1.15 1.27
Dividend Paid and CapEx Coverage Ratio
 -0.09 -0.09 -0.71 -6.78 -3.72
Capital Expenditure Coverage Ratio
 -0.09 -0.09 -0.71 -6.78 -3.72
Operating Cash Flow Coverage Ratio
 >-0.01 >-0.01 -1.45 -2.94 -1.91
Operating Cash Flow to Sales Ratio
 >-0.01 >-0.01 -0.31 -0.62 -0.73
Free Cash Flow Yield
-3.78%-7.15%-18.08%-6.85%-4.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.54 -4.06 -30.21 -7.36 -12.00
Price-to-Sales (P/S) Ratio
 2.53 1.34 4.13 10.32 21.72
Price-to-Book (P/B) Ratio
 0.11 2.09 0.68 1.49 1.98
Price-to-Free Cash Flow (P/FCF) Ratio
 -26.45 -13.98 -5.53 -14.60 -23.54
Price-to-Operating Cash Flow Ratio
 -61.03 -161.19 -13.38 -16.76 -29.87
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.34 -1.40 -0.08
Price-to-Fair Value
 0.11 2.09 0.68 1.49 1.98
Enterprise Value Multiple
 -285.69 -222.27 -12.91 -6.41 -10.58
Enterprise Value
 2.15B 1.67B 1.46B 2.47B 3.68B
EV to EBITDA
 -285.69 -222.27 -12.91 -6.41 -10.58
EV to Sales
 5.38 4.18 4.05 7.36 14.66
EV to Free Cash Flow
 -56.16 -43.70 -5.42 -10.42 -15.89
EV to Operating Cash Flow
 -647.54 -503.80 -13.10 -11.95 -20.17
Tangible Book Value Per Share
 10.76 10.76 4.34 0.99 1.10
Shareholders’ Equity Per Share
 18.20 2.60 4.68 0.99 1.16
Tax and Other Ratios
Effective Tax Rate
 -0.04 -0.04 -0.15 -0.02 >-0.01
Revenue Per Share
 4.06 4.06 0.77 0.14 0.11
Net Income Per Share
 -1.34 -1.34 -0.11 -0.20 -0.19
Tax Burden
 1.04 1.04 1.07 1.02 1.01
Interest Burden
 1.17 1.17 0.34 1.01 1.23
Research & Development to Revenue
 0.15 0.15 0.42 0.71 0.89
SG&A to Revenue
 0.67 0.67 0.62 0.21 0.29
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.03 0.04 0.06
Income Quality
 0.18 0.18 2.41 0.45 0.40
Currency in CNY